Voyager Therapeutics Reports Third Quarter 2021 Financial and Operating Results

NEXT STORY
U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection
PREV STORY
iOnctura to Share Preclinical Data on IOA-289 at SITC in November
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors

author_avatar
NASDAQ Market News

ChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)

author_avatar
NASDAQ Market News

NuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide Vaccine

author_avatar
NASDAQ Market News